Patents by Inventor Philip REDPATH

Philip REDPATH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10815262
    Abstract: The invention relates to methods of preparing nicotinamide riboside and derivatives thereof.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: October 27, 2020
    Assignee: THE QUEEN'S UNIVERSITY OF BELFAST
    Inventors: Marie Migaud, Philip Redpath, Kerri Crossey, Mark Doherty
  • Publication number: 20200291055
    Abstract: Methods of preparing nicotinamide riboside and derivatives thereof.
    Type: Application
    Filed: May 29, 2020
    Publication date: September 17, 2020
    Inventors: Marie MIGAUD, Philip REDPATH, Kerri CROSSEY, Mark DOHERTY
  • Publication number: 20200268778
    Abstract: Methods for stabilizing or encapsulating at least one compound selected from the group consisting of nicotinamide riboside (NR), nicotinic acid riboside (NAR), nicotinamide mononucleotide (NMN), nicotinic acid mononucleotide (NaMN), derivatives thereof, or salts thereof, are provided. Compositions including wax prills, stabilized, or encapsulated forms of at least one compound selected from the group consisting of nicotinamide riboside (NR), nicotinic acid riboside (NAR), and nicotinamide mononucleotide (NMN), derivatives thereof, or salts thereof, are also provided.
    Type: Application
    Filed: February 21, 2020
    Publication date: August 27, 2020
    Applicant: ChromaDex Inc.
    Inventors: Aron Erickson, Amanda Storjohann, Philip Redpath, Matthew Roberts
  • Patent number: 10689411
    Abstract: The present disclosure provides methods of making nicotinoyl riboside compounds or derivatives of formula (I): wherein X?, Z1, Z2, n, R1, R2, R3, R4, R5, R6, R7, and R8 are described herein, reduced analogs thereof, modified derivatives thereof, phosphorylated analogs thereof, and adenylyl dinucleotide conjugates thereof, or salts, solvates, or prodrugs thereof; and novel crystalline forms thereof.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: June 23, 2020
    Assignees: The Queen's University of Belfast, ChromaDex Inc.
    Inventors: Marie Eugenie Migaud, Philip Redpath, Kerri Crossey, Richard Cunningham, Aron Erickson, Richard Nygaard, Amanda Storjohann
  • Publication number: 20200181188
    Abstract: The present disclosure provides crystalline Form II of nicotinic acid riboside, crystalline Form II of nicotinic acid riboside triacetate, and methods of preparation thereof.
    Type: Application
    Filed: December 10, 2019
    Publication date: June 11, 2020
    Applicant: ChromaDex Inc.
    Inventors: Troy Rhonemus, Aron Erickson, Amanda Storjohann, Joshua Holloway, Philip Redpath
  • Patent number: 10280190
    Abstract: Derivatives of nicotinic acid riboside (NAR), nicotinamide riboside (NR), and reduced NAR and NR, including 1-(2?,3?,5?-triacetyl-beta-D-ribofuranosyl)-1,4-dihydronicotinic acid (4a), and compositions containing the same and/or reduced derivative forms of nicotinamide riboside including 1-(2?,3?,5?-triacetyl-beta-D-ribofuranosyl)-1,4-nicotinamide (2), are provided for use in the care of treatment of skin and skin conditions. In some embodiments, the invention relates to pharmaceutical compositions and cosmetic compositions containing one or more NR, NAR, NRH, or NARH derivatives, or prodrugs or salts thereof. In further embodiments, the invention relates to methods of using one or more NR, NAR, NRH, or NARH derivatives, or prodrugs, solvates, or salts thereof, to promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for improving cell and tissue survival and overall cell and tissue health.
    Type: Grant
    Filed: March 16, 2016
    Date of Patent: May 7, 2019
    Assignees: ChromaDex, Inc., The Queen's University of Belfast
    Inventors: Ryan Dellinger, Marie Eugenie Migaud, Philip Redpath, Troy Rhonemus, Richard Cunningham
  • Publication number: 20180258127
    Abstract: The present disclosure provides nicotinate/nicotinamide riboside compounds or derivatives of formula (I): wherein X?, Z1, Z2, n, R1, R2, R3, R4, R5, R6, R7, and R8 are described herein, reduced analogs thereof, and synthetic processes for the preparation thereof.
    Type: Application
    Filed: May 11, 2018
    Publication date: September 13, 2018
    Applicants: ChromaDex Inc., The Queen's University of Belfast
    Inventors: Marie Eugenie Migaud, Philip Redpath, Kerri Crossey, Richard Cunningham, Ryan Dellinger, Troy Rhonemus, Sylesh Venkataraman, Brian Nettles
  • Publication number: 20180186824
    Abstract: The invention relates to methods of preparing nicotinamide riboside and derivatives thereof.
    Type: Application
    Filed: February 27, 2018
    Publication date: July 5, 2018
    Inventors: Marie MIGAUD, Philip REDPATH, Kerri CROSSEY, Mark DOHERTY
  • Patent number: 10000520
    Abstract: The present disclosure provides nicotinate/nicotinamide riboside compounds or derivatives of formula (I): wherein X?, Z1, Z2, n, R1, R2, R3, R4, R5, R6, R7, and R8 are described herein, reduced analogs thereof, and synthetic processes for the preparation thereof.
    Type: Grant
    Filed: March 16, 2017
    Date of Patent: June 19, 2018
    Assignees: ChromaDex Inc., The Queen's University of Belfast
    Inventors: Marie Eugenie Migaud, Philip Redpath, Kerri Crossey, Richard Cunningham, Ryan Dellinger, Troy Rhonemus, Sylesh Venkataraman, Brian Nettles
  • Patent number: 10000519
    Abstract: The invention relates to methods of preparing nicotinamide riboside and derivatives thereof.
    Type: Grant
    Filed: July 24, 2014
    Date of Patent: June 19, 2018
    Assignee: THE QUEEN'S UNIVERSITY OF BELFAST
    Inventors: Marie Migaud, Philip Redpath, Kerri Crossey, Mark Doherty
  • Patent number: 9975915
    Abstract: The present disclosure provides novel crystalline forms of nicotinoyl riboside compounds or derivatives of formula (I): wherein X?, Z1, Z2, n, R1, R2, R3, R4, R5, R6, R7, and R8 are described herein, modified derivatives thereof, and phosphorylated analogs thereof, or salts, solvates, or prodrugs thereof; and methods of preparation thereof.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: May 22, 2018
    Assignees: The Queen's University of Belfast, ChromaDex Inc.
    Inventors: Marie Eugenie Migaud, Philip Redpath, Kerri Crossey, Richard Cunningham, Aron Erickson, Richard Nygaard, Amanda Storjohann
  • Publication number: 20180134743
    Abstract: The present disclosure provides methods of making nicotinoyl riboside compounds or derivatives of formula (I): wherein X?, Z1, Z2, n, R1, R2, R3, R4, R5, R6, R7, and R8 are described herein, reduced analogs thereof, modified derivatives thereof, phosphorylated analogs thereof, and adenylyl dinucleotide conjugates thereof, or salts, solvates, or prodrugs thereof; and novel crystalline forms thereof.
    Type: Application
    Filed: November 10, 2017
    Publication date: May 17, 2018
    Applicants: The Queen's University of Belfast, ChromaDex Inc.
    Inventors: Marie Eugenie Migaud, Philip Redpath, Kerri Crossey, Richard Cunningham, Aron Erickson, Richard Nygaard, Amanda Storjohann
  • Publication number: 20180134742
    Abstract: The present disclosure provides novel crystalline forms of nicotinoyl riboside compounds or derivatives of formula (I): wherein X?, Z1, Z2, n, R1, R2, R3, R4, R5, R6, R7, and R8 are described herein, modified derivatives thereof, and phosphorylated analogs thereof, or salts, solvates, or prodrugs thereof, and methods of preparation thereof.
    Type: Application
    Filed: November 10, 2017
    Publication date: May 17, 2018
    Applicants: The Queen's University of Belfast, ChromaDex Inc.
    Inventors: Marie Eugenie Migaud, Philip Redpath, Kerri Crossey, Richard Cunningham, Aron Erickson, Richard Nygaard, Amanda Storjohann
  • Publication number: 20170267709
    Abstract: The present disclosure provides nicotinate/nicotinamide riboside compounds or derivatives of formula (I): wherein X?, Z1, Z2, n, R1, R2, R3, R4, R5, R6, R7, and R8 are described herein, reduced analogs thereof, and synthetic processes for the preparation thereof.
    Type: Application
    Filed: March 16, 2017
    Publication date: September 21, 2017
    Applicants: ChromaDex Inc., The Queen's University of Belfast
    Inventors: Marie Eugenie Migaud, Philip Redpath, Kerri Crossey, Richard Cunningham, Ryan Dellinger, Troy Rhonemus, Sylesh Venkataraman, Brian Nettles
  • Publication number: 20160355539
    Abstract: A synthetic process is provided for the preparation of phosphorylated analogs of nicotinamide riboside (“NR”) having the formula (I), or salts thereof, and reduced or modified derivatives thereof, having the formula (II), wherein X?, Y1, Y2, Z1, Z2, n, R1, R2, R3, R4, R5, R6, and R7 are as defined herein. The present disclosure also relates to the preparation of phosphorylated analogs of nicotinic acid riboside (“NAR”) having the formula (I), or salts thereof, and reduced or modified derivatives thereof, having the formula (II). Generally solvent-free conditions are employed using appropriate mechano-chemical techniques as described.
    Type: Application
    Filed: June 3, 2016
    Publication date: December 8, 2016
    Applicants: ChromaDex, Inc., The Queen's University of Belfast
    Inventors: Marie Eugenie Migaud, Philip Redpath, Kerri Crossey, Richard Cunningham, Troy Rhonemus, Sylesh Venkataraman
  • Publication number: 20160272668
    Abstract: Derivatives of nicotinic acid riboside (NAR), nicotinamide riboside (NR), and reduced NAR and NR, including 1-(2?,3?,5?-triacetyl-beta-D-ribofuranosyl)-1,4-dihydronicotinic acid (4a), and compositions containing the same and/or reduced derivative forms of nicotinamide riboside including 1-(2?,3?,5?-triacetyl-beta-D-ribofuranosyl)-1,4-nicotinamide (2), are provided for use in the care of treatment of skin and skin conditions. In some embodiments, the invention relates to pharmaceutical compositions and cosmetic compositions containing one or more NR, NAR, NRH, or NARH derivatives, or prodrugs or salts thereof. In further embodiments, the invention relates to methods of using one or more NR, NAR, NRH, or NARH derivatives, or prodrugs, solvates, or salts thereof, to promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for improving cell and tissue survival and overall cell and tissue health.
    Type: Application
    Filed: March 16, 2016
    Publication date: September 22, 2016
    Applicants: ChromaDex Inc., The Queen's University of Belfast
    Inventors: Ryan Dellinger, Marie Eugenie Migaud, Philip Redpath, Troy Rhonemus, Richard Cunningham
  • Publication number: 20160168184
    Abstract: The invention relates to methods of preparing nicotinamide riboside and derivatives thereof.
    Type: Application
    Filed: July 24, 2014
    Publication date: June 16, 2016
    Inventors: Marie MIGAUD, Philip REDPATH, Kerri CROSSEY, Mark DOHERTY